Document is current
Any future updates will be listed below
-
Authors
Kong, Maximilian D.
Bailey, Johnathan A.
Exinor, Abdhel
Piamjitchol, Chanakarn
Demirkol, Aykut
Tsang, Stephen H. https://orcid.org/0000-0001-9082-2427
-
Funding
Funding for this research was provided by:
National Eye Institute (U01EY030580, U01EY034590, R24EY028758, R24EY027285, R01EY033770, R01EY018213, R01EY024698)
Foundation Fighting Blindness (TA-GT-0321-0802-COLU-TRAP)
Richard Jaffe Foundation
NYEE Foundation
Rosenbaum Family Foundation
Gebroe Family Foundation
Research to Prevent Blindness (Physician-Scientist Award)
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 20 February 2025
First Online: 12 March 2025
Declarations
:
: S.H.T receives financial support from Abeona Therapeutics, Inc. and from Emendo, and is on the scientific and clinical advisory board for Nanoscope Therapeutics.
: Informed consent was obtained from all individual participants included in the study.
: The study was conducted under the Columbia University Institutional Review Board-approved protocol IRB AAAR8743, and all procedures were performed in accordance with the tenets of the Declaration of Helsinki.
: This study did not involve the use of animals. No animal subjects were included in the case reports, and no procedures were performed on animals. As such, ethical approval for animal research was not required.
